President Donald Trump on Friday will announce that pharmaceutical giant AstraZeneca has struck a deal to sell its drugs to the Medicaid program at a discount, making it the second company to publicly agree to the Trump’s administration’s push for lower drug prices, according to three people who spoke on the condition of anonymity to preview the planned announcement.
